Levonorgestrel Tablet
Product Images NDC 51660-723

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Levonorgestrel (NDC 51660-723). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ohm Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (1.5 mg Tablet Blister Pack Carton)

Principal Display Panel (1.5 mg Tablet Blister Pack Carton)
MY AFTER PLAN is a levonorgestrel emergency contraceptive tablet that helps reduce the chance of pregnancy after unprotected sex. It is not for regular birth control. The inactive ingredients include colicin, silicon dioxide, corn starch, and more. If you have any questions or comments, call 8008184555. The trademark is owned by Sun Pharmaceutical Industries Limited and is distributed by Ohm Laboratories in New Brunswick. The expiration date is not specified.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.